National Health Commission: Azulfidine tablets for adult patients with medium-sized novel coronavirus infection
Read Time:39 Second
The National Health Care Commission issued a protocol for the treatment of severe cases of novel coronavirus infection (trial version 4). It is proposed that the combination package of nematovir/ritonavir tablets (Paxlovid) is used for adult patients with mild to moderate disease within 5 days of onset and with high risk factors for progression to severe disease. Azivudine tablets are used in adult patients with intermediate-sized novel coronavirus infections. Monoprevir capsules are used in adult patients with mild to moderate disease within 5 days of onset and with risk factors for progression to severe disease. In patients with severe disease, the above drugs may also be used if the disease is of short duration, especially if the nucleic acid load is high (Ct value <30).
Happy
0 %
Sad
0 %
Excited
0 %
Sleepy
0 %
Angry
0 %
Surprise
0 %
0
0
Average Rating